Glucose 40% w/v Solution for Injection

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Glucose Anhydrous

Available from:

Dechra Limited

ATC code:

QB05BA03

INN (International Name):

Glucose Anhydrous

Pharmaceutical form:

Solution for injection

Prescription type:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Therapeutic group:

Cattle, Sheep

Therapeutic area:

Replacement Agent

Authorization status:

Authorized

Authorization date:

1994-04-20

Summary of Product characteristics

Revised: September 2016
AN: 00798/2016
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Glucose 40% w/v Solution for Injection
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE
Qualitative composition
Glucose (anhydrous)
EXCIPIENTS
For a full list of excipients, see
section 6.1.
Quantitative composition
40.00 % w/v
3.
PHARMACEUTICAL FORM
Solution for injection.
A clear, sterile, aqueous solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle and sheep.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of primary and secondary hypoglycaemia, acetonaemia
and as a source of energy in cattle.
As an aid in the treatment of pregnancy toxaemia in sheep.
4.3
CONTRAINDICATIONS
Do not give by subcutaneous injection.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Intravenous injection should be given slowly, preferably not exceeding
0.5
ml/kg/hour.
Do not administer by the subcutaneous route.
When acidosis is severe, and renal failure present, treatment is
unlikely to be
efficacious.
4.5
SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals
This product does not contain an antimicrobial preservative. Any
solution
Revised: September 2016
AN: 00798/2016
Page 2 of 4
remaining in the vial following withdrawal of the required dose should
be
discarded.
ii.
Special precautions for the person administering the veterinary
medicinal
product to animals
Care should be taken to avoid accidental self-injection.
Wash hands after use.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Rapid intravenous injection of dextrose will cause the renal threshold
for
glucose to be exceeded, with consequent clinical signs of stress and
loss of
glucose in the urine. For best results intravenous infusions should be
given
slowly, preferably at a rate not exceeding 0.5 ml/kg/hour.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Not contraindicated.
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None known (supplementary treatment can be